Introduction
Material and methods
Patients
Treatment and data collection
Prognosis definition
Statistical analysis
Results
Patient characteristics
AFR | |||
---|---|---|---|
Parameters | Low (≤7.78) | High (> 7.78) | p value |
Number | 151 | 162 | – |
Age (years) | 65.8 ± 8.7 | 63.1 ± 7.8 | 0.004* |
BMI (kg/m2) | 23.1 ± 2.3 | 23.4 ± 2.1 | 0.229 |
Current smokers (n, %) | 18 (11.9) | 24 (14.8) | 0.453 |
Alcohol (n, %) | 14 (9.3) | 19 (11.7) | 0.479 |
Comorbidities (n, %) | – | ||
Diabetes | 22 (14.6) | 17 (10.5) | 0.275 |
Hypertension | 27 (17.9) | 22 (13.6) | 0.295 |
Hyperlipemia | 15 (9.9) | 12 (7.4) | 0.426 |
Histological grade (n, %) | 0.042* | ||
G1 | 76 (50.3) | 100 (61.7) | – |
G2/3 | 75 (49.7) | 62 (38.3) | – |
Histological type (n, %) | 0.444 | ||
Serous | 106 (70.2) | 120 (74.1) | – |
Non-serous | 45 (29.8) | 42 (25.9) | – |
FIGO stage (n, %) | 0.032* | ||
III | 113 (74.8) | 137 (84.6) | – |
IV | 38 (25.2) | 25 (15.4) | – |
ECOG PS (n, %) | 0.016* | ||
0 | 101 (66.9) | 128 (79.0) | – |
≥ 1 | 50 (33.1) | 34 (21.0) | – |
Chemotherapy resistance (n, %) | 54 (35.8) | 40 (24.7) | 0.033* |
Residual tumor (cm) | 0.005* | ||
≤ 1 | 100 (66.2) | 130 (80.2) | – |
> 1 | 51 (33.8) | 32 (19.8) | – |
AFR | |||
---|---|---|---|
Laboratory tests | Low (≤7.78) | High (> 7.78) | p value |
Hemoglobin (g/L) | 102.4 ± 11.5 | 104.1 ± 12.5 | 0.212 |
Platelet (109/L) | 164.4 ± 35.8 | 170.7 ± 41.3 | 0.152 |
WBC(109/L) | 7.0 ± 1.9 | 7.2 ± 2.2 | 0.392 |
Albumin (g/L) | 38.9 ± 4.6 | 39.2 ± 3.9 | 0.533 |
Total protein (g/L) | 70.1 ± 7.8 | 69.6 ± 6.5 | 0.537 |
Total cholesterol (mmol/L) | 4.3 ± 0.6 | 4.2 ± 0.7 | 0.177 |
Triglyceride (mmol/L) | 1.2 ± 0.5 | 1.3 ± 0.5 | 0.078 |
CRP (ng/L) | 7.4 ± 10.1 | 5.3 ± 7.1 | 0.033* |
CA125 (U/mL) | 145.1 ± 189.3 | 87.2 ± 128.1 | 0.002* |
Risk factors for PFS and OS in advanced EOC patients
Univariate | Multivariate | |||
---|---|---|---|---|
Parameters | HR(95% CI) | p value | HR(95% CI) | p value |
Age (high vs low) | 1.50 (1.11–2.08) | 0.016* | 1.17 (0.85–1.62) | 0.301 |
BMI (high vs low) | 0.82 (0.61–1.15) | 0.251 | ||
Current smokers (yes vs no) | 1.28 (0.97–1.70) | 0.112 | ||
Alcohol (yes vs no) | 1.16 (0.89–1.53) | 0.247 | ||
Diabetes (yes vs no) | 1.03 (0.75–1.41) | 0.822 | ||
Hypertension (yes vs no) | 1.06 (0.73–1.49) | 0.794 | ||
Hyperlipemia (yes vs no) | 0.85 (0.42–1.65) | 0.654 | ||
Histological grade (G2/3 vs G1) | 1.76 (1.19–2.63) | 0.012* | 1.63 (0.92–2.77) | 0.093 |
Histological type (serous vs non-serous) | 1.21 (0.89–1.59) | 0.179 | ||
FIGO stage (IV vs III) | 1.72 (1.09–2.73) | 0.024* | 1.44 (0.79–2.69)0.254 | |
ECOG PS (≥1 vs 0) | 0.86 (0.71–1.07) | 0.852 | ||
Chemotherapy resistance (yes vs no) | 2.07 (1.35–3.17) | 0.011* | 1.84 (1.12–2.88) | 0.032* |
Residual tumor (> 1 cm vs ≤1 cm) | 2.01 (0.94–4.31) | 0.071 | 1.61 (0.91–2.85) | 0.121 |
Hemoglobin (high vs low) | 1.84 (0.69–4.78) | 0.211 | ||
Platelet (high vs low) | 1.55 (0.38–5.78) | 0.529 | ||
WBC (high vs low) | 1.86 (0.86–3.89) | 0.127 | ||
Albumin (high vs low) | 0.92 (0.57–1.42) | 0.721 | ||
Total protein (high vs low) | 0.81 (0.44–1.48) | 0.472 | ||
Total cholesterol (high vs low) | 0.75 (0.47–1.24) | 0.261 | ||
Triglyceride (high vs low) | 1.26 (0.70–2.22) | 0.425 | ||
CA125 (high vs low) | 1.72 (1.22–2.44) | 0.011* | 1.42 (1.02–2.05) | 0.042* |
CRP (high vs low) | 1.36 (0.69–2.64) | 0.373 | ||
AFR (≤7.78 vs > 7.78) | 1.56 (1.21–2.05) | 0.007* | 1.38 (1.04–1.82) | 0.019* |
Univariate | Multivariate | |||
---|---|---|---|---|
Parameters | HR(95% CI) | p value | HR(95% CI) | p value |
Age (high vs low) | 1.23 (0.84–1.81) | 0.304 | ||
BMI (high vs low) | 0.53 (0.24–1.15) | 0.112 | ||
Current smokers (yes vs no) | 1.09 (0.76–1.57) | 0.647 | ||
Alcohol (yes vs no) | 1.17 (0.82–1.67) | 0.384 | ||
Diabetes (yes vs no) | 1.24 (0.71–2.13) | 0.435 | ||
Hypertension (yes vs no) | 1.31 (0.83–2.05) | 0.247 | ||
Hyperlipemia (yes vs no) | 0.85 (0.54–1.33) | 0.468 | ||
Histological grade (G2/3 vs G1) | 1.57 (1.03–2.41) | 0.034* | 0.92 (0.81–1.22) | 0.068 |
Histological type (serous vs non-serous) | 0.49 (0.83–2.64) | 0.181 | ||
FIGO stage (IV vs III) | 1.89 (1.17–3.11) | 0.014* | 1.58 (0.77–3.35) | 0.221 |
ECOG PS (≥1 vs 0) | 1.12 (0.74–1.69) | 0.603 | ||
Chemotherapy resistance (yes vs no) | 1.27 (1.03–1.62) | 0.021* | 1.30 (1.01–1.67) | 0.032* |
Residual tumor (> 1 cm vs ≤1 cm) | 1.32 (1.04–1.68) | 0.022* | 1.48 (1.01–2.21) | 0.046* |
Hemoglobin (high vs low) | 0.78 (0.39–1.56) | 0.478 | ||
Platelet (high vs low) | 1.55 (0.75–3.18) | 0.237 | ||
WBC (high vs low) | 1.39 (0.77–2.51) | 0.278 | ||
Albumin (high vs low) | 0.65 (0.38–1.12) | 0.112 | ||
Total protein (high vs low) | 0.89 (0.55–1.45) | 0.642 | ||
Total cholesterol (high vs low) | 0.69 (0.31–1.52) | 0.359 | ||
Triglyceride (high vs low) | 1.50 (0.83–2.73) | 0.181 | ||
CA125 (high vs low) | 1.41 (0.73–2.73) | 0.304 | ||
CRP (high vs low) | 1.17 (0.64–2.11) | 0.613 | ||
AFR (≤7.78 vs > 7.78) | 2.50 (1.44–4.09) | 0.007* | 2.19 (1.18–3.67) | 0.021* |